References
1. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomised, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340(6):409-417. https://doi. org/10.1056/nejm199902113400601 2. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371(15):1381-1391. https://doi.org/10.1056
1. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomised, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340(6):409-417. https://doi. org/10.1056/nejm199902113400601
2. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371(15):1381-1391. https://doi.org/10.1056/nejmoa1406617
3. Bergamin FS, de Almeida JP, Landoni G, et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomised Controlled Trial. Crit Care Med 2017;45(5):766-773. https://doi.org/10.1097/ ccm.0000000000002283
4. De Almeida JP, Vincent JL, Galas FR, et al. Transfusion requirements in surgical oncology patients: A prospective, randomised controlled trial. Anesthesiology 2015;122(1):29-38. https:// doi.org/10.1097/aln.0000000000000511
5. Walsh TS, Boyd JA, Watson D, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: A randomised pilot trial. Crit Care Med 2013;41(10):2354-2363. https://doi.org/10.1097/ccm.0b013e318291cce4
6. Sakr Y, Lobo S, Knuepfer S, et al. Anemia and blood transfusion in a surgical intensive care unit. Crit Care 2010;14(3):R92. https://doi.org/10.1186/cc9026
7. Yealy DM, Kellum JA, Huang DT, et al. A randomised trial of protocol-based care for early septic shock. N Engl J Med 2014;370(18):1683-1693. https://doi.org/10.1056/nejmoa1401602
8. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: Systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 2015;350:h1354. https://doi.org/10.1136/bmj.h1354
9. Fominskiy E, Putzu A, Monaco F, et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. Br J Anaesth 2015;115(4):511-519. https://doi.org/10.1093/bja/aev317
10. Chong MA, Krishnan R, Cheng D, Martin J. Should transfusion trigger thresholds differ for critical care versus perioperative patients? A meta-analysis of randomised trials. Crit Care Med 2018;46(2):252-263. https://doi.org/10.1097%2FCCM.0000000000002873
11. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288(12):1499-1507. https://doi.org/10.1001/jama.288.12.1499
12. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 2000;87(11):1553-1562. https://doi.org/10.1046/j.1365-2168.2000.01570.x
13. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database of Syst Rev 2006(1):CD005033.
14. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013;110(5):690-701. https://doi.org/10.1093/bja/aet068
15. Dupuis C, Sonneville R, Adrie C, et al. Impact of transfusion on patients with sepsis admitted in intensive care unit: A systematic review and meta-analysis. Ann Intensive Care 2017;7(1):5. https://doi.org/10.1186%2Fs13613-016-0226-5
16. Parsons EC, Hough CL, Seymour CW, Cooke CR, Rubenfeld GD, Watkins TR. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care 2011;15(5):R221. https://doi.org/10.1186/cc10458
17. Peake SL, Bailey M, Bellomo R, et al. Australasian resuscitation of sepsis evaluation (ARISE): A multi-centre, prospective, inception cohort study. Resuscitation 2009;80(7):811-818. https://doi. org/10.1016/j.resuscitation.2009.03.008
18. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015;372(14):1301-1311. https://doi.org/10.1056/nejmoa1500896
19. Mark DG, Morehouse JW, Hung YY, et al. In-hospital mortality following treatment with red blood cell transfusion or inotropic therapy during early goal-directed therapy for septic shock: A retrospective propensity-adjusted analysis. Critical Care 2014;18(5):496. https://doi. org/10.1186%2Fs13054-014-0496-y
20. Hsu C-Y, Liu S-H, Chao C-H, et al. STROBE-compliant article: Blood transfusions within the first 24 hours of hospitalisation did not impact mortality among patients with severe sepsis. Medicine 2016;95(4):e2601. https://doi.org/10.1097/md.0000000000002601
21. Hebert PC. Clinical outcomes following institution of the Canadian Universal Leukoreduction Program for red blood cell transfusions. JAMA 2003;289(15):1941-1949.
22. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis. JAMA 2014;311(13):1317-1326. https://doi. org/10.1001%2Fjama.2014.2726
23. Juffermans NP, Prins DJ, Vlaar AP, Nieuwland R, Binnekade JM. Transfusion-related risk of secondary bacterial infections in sepsis patients: A retrospective cohort study. Shock 2011;35(4):355-359. https://doi.org/10.1097/shk.0b013e3182086094
24. Sakr Y, Chierego M, Piagnerelli M, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007;35(7):1639-1644. https://doi.org/10.1097/01. ccm.0000269936.73788.32
25. Plataki M, Kashani K, Cabello-Garza J, et al. Predictors of acute kidney injury in septic shock patients: An observational cohort study. Clin J Am Soc Neph 2011;6(7):1744-1751. https://doi. org/10.2215/cjn.05480610
26. Engoren M. Does erythrocyte blood transfusion prevent acute kidney injury?: Propensitymatched case control analysis. Anesthesiology 2010;113(5):1126-1133. https://doi.org/10.1097/ aln.0b013e181f70f56
27. Legrand M, Dupuis C, Simon C, et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: A retrospective observational study. Critical Care 2013;17(6):R278. https://doi.org/10.1186/cc13133
28. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130(25):2354-2394.
29. Lawler PR, Filion KB, Dourian T, Atallah R, Garfinkle M, Eisenberg MJ. Anemia and mortality in acute coronary syndromes: A systematic review and meta-analysis. Am Heart J 2013;165(2):143- 153.e5. https://doi.org/10.1016/j.ahj.2012.10.024
30. Hasin T, Sorkin A, Markiewicz W, Hammerman H, Aronson D. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction. Am J Cardiol 2009;104(4):486-491. https://doi.org/10.1016/j.amjcard.2009.03.066
31. Mamas MA, Kwok CS, Kontopantelis E, et al. Relationship between anemia and mortality outcomes in a national acute coronary syndrome cohort: Insights from the UK Myocardial Ischemia National Audit Project Registry. J Am Heart Assoc 2016;5(11). https://doi.org/10.1161/ jaha.116.003348
32. Pawloski JR, Stamler JS. Nitric oxide in RBCs. Transfusion 2002;42(12):1603-1609.
33. Zimmerman R, Tsai AG, Salazar Vazquez BY, et al. Posttransfusion increase of hematocrit per se does not improve circulatory oxygen delivery due to increased blood viscosity. Anesth Analg 2017;124(5):1547-1554. https://doi.org/10.1213/ane.0000000000002008
34. Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 2017;377(22):2133-2144. https://doi.org/10.1056/nejmoa1711818
35. Shehata N, Whitlock R, Fergusson DA, et al. Transfusion requirements in cardiac surgery III (TRICS III): Study design of a randomised controlled trial. J Cardiothorac Vasc Anesth 2018;32(1):121-129. https://doi.org/10.1053/j.jvca.2017.10.036
36. Docherty AB, O’Donnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: Systematic review and meta-analysis. BMJ 2016;352:i1351. https://doi.org/10.1136/bmj.i1351
37. Chatterjee S, Wetterslev J, Mukherjee D. Patient-level vs group-level data to adjust meta-analysis on transfusion and mortality-reply. JAMA Intern Med 2013;173(12):1157-1158. https://doi.org/10.1001/ jamainternmed.2013.6852
38. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: A meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med 2013;173(2):132-139. https://doi.org/10.1001/2013.jamainternmed.1001
39. Stucchi M, Cantoni S, Piccinelli E, Savonitto S, Morici N. Anemia and acute coronary syndrome: Current perspectives. Vasc Health Risk Manag 2018;14:109-118. https://doi.org/10.2147%2FVHRM. S140951
40. Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: A clinical practice guideline from the AABB. Ann Intern Med 2015;162(3):205-213.
41. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993;34(2):216-222.
42. Graham DI, Ford I, Adams JH, et al. Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psych 1989;52(3):346-350.
43. Walsh TS, Saleh E-E-D. Anaemia during critical illness. Br J Anaesth 2006;97(3):278-291.
44. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiol 2000;92(6):1646-1652.
45. McLaren AT, David Mazer C, Zhang H, Liu E, Mok L, Hare GMT. A potential role for inducible nitric oxide synthase in the cerebral response to acute hemodilution. Can J Anesth 2009;56(7):502-509. https://doi.org/10.1007/s12630-009-9104-z
46. Lelubre C, Bouzat P, Crippa IA, Taccone FS. Anemia management after acute brain injury. Crit Care 2016;20(1).
47. Duane TM, Mayglothling J, Grandhi R, et al. The effect of anemia and blood transfusions on mortality in closed head injury patients. J Surg Res 2008;147(2):163-167. https://doi.org/10.1016/j. jss.2008.02.044
48. Van Beek JGM, Mushkudiani NA, Steyerberg EW, et al. Prognostic value of admission laboratory parameters in traumatic brain injury: Results from The IMPACT Study. J Neurotrauma 2007;24(2):315-328. https://doi.org/10.1089/neu.2006.0034
49. Sekhon MS, McLean N, Henderson WR, Chittock DR, Griesdale DEG. Association of hemoglobin concentration and mortality in critically ill patients with severe traumatic brain injury. Crit Care 2012;16(4):R128. https://doi.org/10.1186/cc11431
50. Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 2008;5(8):e165. https://doi.org/10.1371/journal.pmed.0050165
51. Kramer AH, Zygun DA. Anemia and red blood cell transfusion in neurocritical care. Crit Care 2009;13(3):R89. https://doi.org/10.1186/cc7916
52. McIntyre LA, Fergusson DA, Hutchison JS, et al. Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury. Neurocrit Care 2006;5(1):4-9. https://doi.org/10.1385/ncc:5:1:4
53. Carlson AP, Schermer CR, Lu SW. Retrospective evaluation of anemia and transfusion in traumatic brain injury. J Trauma 2006;61(3):567-571. https://doi.org/10.1097/01.ta.0000231768.44727.a2
54. Robertson CS, Hannay HJ, Yamal JM, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: A randomised clinical trial. JAMA 2014;312(1):36- 47. https://doi.org/10.1001/jama.2014.6490
55. Leal-Noval SR, Múñoz-Gómez M, Murillo-Cabezas F. Optimal hemoglobin concentration in patients with subarachnoid hemorrhage, acute ischemic stroke and traumatic brain injury. Curr Opin Crit Care 2008;14(2):156-162. https://doi.org/10.1097/mcc.0b013e3282f57577
56. Elterman J, Brasel K, Brown S, et al. Transfusion of red blood cells in patients with a prehospital Glasgow Coma Scale score of 8 or less and no evidence of shock is associated with worse outcomes. J Traum Acute Care Surg 2013;75(1):8-14. https://doi.org/10.1097/ta.0b013e318298492e
57. Boutin A, Moore L, Lauzier F, et al. Transfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: A multicentre cohort study. BMJ Open 2017;7(3):e014472. https://doi.org/10.1136/bmjopen-2016-014472
58. Almeida KJ, Rodrigues ÂB, Lemos LEAS, et al. Hemotransfusion and mechanical ventilation time are associated with intra-hospital mortality in patients with traumatic brain injury admitted to intensive care unit. Arquivos de Neuro-Psiquiatria 2016;74(8):644-649. https://doi.org/10.1590/0004- 282x20160093
59. Boutin A, Chassé M, Shemilt M, et al. Red blood cell transfusion in patients with traumatic brain injury: A systematic review and meta-analysis. Transfus Med Rev 2016;30(1):15-24. https://doi. org/10.1016/j.tmrv.2015.08.004
60. Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: Fifth edition. Crit Care 2019;23(1):98. https://doi.org/10.1186/ s13054-019-2347-3
61. The American Society of Anesthesiologists Committee on Standards and Practice Parameters and the Task Force on Perioperative Blood Management Practice guidelines for perioperative blood management: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiol 2015;122(2):241-275.
62. Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury. Crit Care Med 2009;37(3):1074-1078. https://doi.org/10.1097/ccm.0b013e318194ad22
63. Smith MJ, Stiefel MF, Magge S, et al. Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 2005;33(5):1104-1108. https://doi.org/10.1097/01. ccm.0000162685.60609.49
64. Dhar R, Zazulia AR, Derdeyn CP, Diringer MN. RBC transfusion improves cerebral oxygen delivery in subarachnoid hemorrhage. Crit Care Med 2017;45(4):653-659. https://doi.org/10.1097/ ccm.0000000000002266
65. Kramer AH, Diringer MN, Suarez JI, Naidech AM, Macdonald LR, Le Roux PD. Red blood cell transfusion in patients with subarachnoid hemorrhage: A multidisciplinary North American survey. Critcal Care 2011;15(1):R30. https://doi.org/10.1186/cc9977
66. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: A systematic review. Crit Care 2010;14(1):R23. https://doi.org/10.1186/cc8886
67. Festic E, Rabinstein AA, Freeman WD, et al. Blood transfusion is an important predictor of hospital mortality among patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2013;18(2):209-215. https://doi.org/10.1007/s12028-012-9777-y
68. Naidech AM, Shaibani A, Garg RK, et al. Prospective, randomised trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care 2010;13(3):313-320. https://doi.org/10.1007/s12028- 010-9424-4
69. Kurtz P, Helbok R, Claassen J, et al. The effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Neurocrit Care 2016;24(1):118- 121. https://doi.org/10.1186%2Fcc8573
70. English SW, Chasse M, Turgeon AF, et al. Anemia prevalence and incidence and red blood cell transfusion practices in aneurysmal subarachnoid hemorrhage: Results of a multicenter cohort study. Crit Care 2018;22(1):169. https://doi.org/10.1186%2Fs13054-018-2089-7
71. Badenes R, Oddo M, Suarez JI, et al. Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: An international survey. Crit Care 2017;21(1):159. https://doi. org/10.1186/s13054-017-1748-4
72. Kaiafa G, Savopoulos C, Kanellos I, et al. Anemia and stroke: Where do we stand? Acta Neurol Scand 2017;135(6):596-602. https://doi.org/10.1111/ane.12657
73. Liu K, Song B, Gao Y, et al. Long-term outcomes in patients with anemia and cerebral venous thrombosis. Neurocrit Care 2018;29(3):463-468. https://doi.org/10.1007/s12028-018-0544-6
74. Sharma K, Johnson DJ, Johnson B, Frank SM, Stevens RD. Hemoglobin concentration does not impact 3-month outcome following acute ischemic stroke. BMC Neurol 2018;18(1):78. https://doi. org/10.1186/s12883-018-1082-8
75. Barlas RS, Honney K, Loke YK, et al. Impact of hemoglobin levels and anemia on mortality in acute stroke: Analysis of UK regional registry data, systematic review, and meta-analysis. J Am Heart Assoc 2016;5(8):e003019. https://doi.org/10.1161/jaha.115.003019
76. Cannon JW, Khan MA, Raja AS, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 2017;82(3):605-617. https://doi.org/10.1097/ ta.0000000000001333
77. Shaz BH, Dente CJ, Harris RS, MacLeod JB, Hillyer CD. Transfusion management of trauma patients. Anesth Analg 2009;108(6):1760-1768. https://doi.org/10.1213%2Fane.0b013e3181a0b6c6
78. Osaro E, Charles AT. The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: The need for the development of alternatives to allogenic blood. J Blood Med 2011;2:7-21. https://doi.org/10.2147%2FJBM.S17194
79. Hardcastle TC, Samuels C, Muckart DJ. An assessment of the hospital disease burden and the facilities for the in-hospital care of trauma in KwaZulu-Natal, South Africa. World J Surg 2013;37(7):1550-1561. https://doi.org/10.1007/s00268-012-1889-1
80. Hebert PC. Clinical outcomes following institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions. JAMA 2013;289(15):1941-1949. https://doi.org/10.1001/ jama.289.15.1941
81. Van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomised clinical trial. Circulation 1998;97(6):562-568. https://doi.org/10.1161/01.cir.97.6.562
82. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371(15):1381-1391. https://doi.org/10.1056/nejmoa1406617
83. Sakr Y, Lobo S, Knuepfer S, et al. Anemia and blood transfusion in a surgical intensive care unit. Crit Care 2010;14(3):R92. https://doi.org/10.1186%2Fcc9026
84. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomised Pilot Study). J Am Cardiol 2011;108(8):1108-1111. https://doi.org/10.1016/j.amjcard.2011.06.014
85. Bhangu A, Nepogodiev D, Doughty H, Bowley DM. Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury 2013;44(12):1693-1699. https://doi. org/10.1016/j.injury.2012.07.193
86. Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA. Erythropoietin-receptor agonists in critically ill patients: A meta-analysis of randomised controlled trials. CMAJ 2007;177(7):725-734. https://doi.org/10.1503%2Fcmaj.071055
87. Luchette FA, Pasquale MD, Fabian TC, Langholff WK, Wolfson M. A randomised, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects: The Long Term Trauma Outcomes Study. Am Surg 2012;203(4):508-516. https://doi.org/10.1016/j.amjsurg.2011.08.006
88. Lundy JB, Hetz K, Chung KK, et al. Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. Am Surg 2010;76(9):951-956.
89. Nichol A, French C, Little L, et al. Erythropoietin in traumatic brain injury (EPO-TBI): A doubleblind randomised controlled trial. Lancet 2015;386(10012):2499-2506. https://doi.org/10.1016/ s0140-6736(15)00386-4
90. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007;357(10):965-976. https://doi.org/10.1056/nejmoa071533
91. Munoz M, Breymann C, Garcia-Erce JA, Gomez-Ramirez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sanguinis 2008;94(3):172-183. https://doi.org/10.1111/j.1423-0410.2007.01014.x
92. Shah A, Roy NB, McKechnie S, Doree C, Fisher SA, Stanworth SJ. Iron supplementation to treat anaemia in adult critical care patients: A systematic review and meta-analysis. Crit Care 2016;20(1):306. https://doi.org/10.1186/s13054-016-1486-z
93. Litton E, Baker S, Erber WN, et al. Intravenous iron or placebo for anaemia in intensive care: The IRONMAN multicentre randomised blinded trial: A randomised trial of IV iron in critical illness. Intensive Care Med 2016;42(11):1715-1722. https://doi.org/10.1007/s00134-016-4465-6
94. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010;105(4):401-416.
95. Wee M, Kuppurao L. Perioperative cell salvage. Cont Educ Anaes Crit Care Pain. 2010;10(4):104- 108. https://doi.org/10.1093/bja/aeq244
96. Solomon L, von Rahden RP, Allorto NL. Intra-operative cell salvage in South Africa: Feasible, beneficial and economical. S Afr Med J 2013;103(10):754-757.
97. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010(3):Cd001888. https:// doi.org/10.1002/14651858.cd001888.pub2
98. Mer M, Hodgson E, Wallis L, et al. Hemoglobin glutamer-250 (bovine) in South Africa: Consensus usage guidelines from clinician experts who have treated patients. Transfusion 2016;56(10):2631- 2636. https://doi.org/10.1111/trf.13726
99. Levien LJ. South Africa: Clinical experience with Hemopure. ISBT Science Series 2006;1(1):167-173.
100. Mackenzie CF, Shander A. What to do if no blood is available but the patient is bleeding? S Afr J Anaesth Analg 2008;14(1):39-43.
101. Potgieter HE, James MF. The use of Hemopure at Groote Schuur hospital, Cape Town: 4 case studies. S Afr J Anaesth Analgia 2009;15(1):13-15.
102. Weiskopf RB, Silverman TA. Balancing potential risks and benefits of hemoglobin-based oxygen carriers. Transfusion 2013;53(10):2327-2333. https://doi.org/10.1111/trf.12339
103. Rice TW, Wheeler AP. Coagulopathy in critically ill patients: Part 1: Platelet disorders. Chest 2009;136(6):1622-1630. https://doi.org/10.1378/chest.08-2534
104. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review. Chest 2011;139(2):271-278. https://doi.org/10.1378/chest.10-2243
105. Lauzier F, Arnold DM, Rabbat C, et al. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med 2013;39(12):2135-2143. https:// doi.org/10.1007/s00134-013-3044-3
106. Lieberman L, Bercovitz RS, Sholapur NS, Heddle NM, Stanworth SJ, Arnold DM. Platelet transfusions for critically ill patients with thrombocytopenia. Blood 2014;123(8):1146-1151. https:// doi.org/10.1182/blood-2013-02-435693
107. McIntyre L, Tinmouth AT, Fergusson DA. Blood component transfusion in critically ill patients. Curr Opin Crit Care 2013;19(4):326-333. https://doi.org/10.1097/mcc.0b013e3283632e56
108. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DL. Thrombocytopenia and platelet transfusion in UK critical care: A multicenter observational study. Transfusion 2013;53(5):1050-1058. https://doi.org/10.1111/j.1537-2995.2012.03866.x
109. Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane database Syst Rev 2016;10:CD002042. https://doi. org/10.1002/14651858.cd002042.pub4
110. Estcourt LJ, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions. Br J Haematol 2017;176(3):365-394. https://doi.org/10.1111/bjh.14423
111. Dzik WH, Blajchman MA, Fergusson D, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products-Massive Transfusion Consensus Conference 2011: Report of the panel. Crit Care 2011;15(6):242. https://doi.org/10.1186/cc10498
112. Triulzi DJ. The art of plasma transfusion therapy. Transfusion 2006;46(8):1268-1270. https://doi. org/10.1111/j.1537-2995.2006.00923.x
113. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006;46(8):1279- 1285. https://doi.org/10.1111/j.1537-2995.2006.00891.x
114. Friedman K, Menitove J. Preparation and clinical use of plasma and plasma fractions. In: Beutler E, Lichtman M, Coller B, Kipps T, Seligsohn U, eds. Williams’ Hematology. 6th ed. New York: McGraw-Hill, 2001:1917.
115. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm? Crit Care Med 2006;34(5 Suppl):S170-173. https://doi. org/10.1097/01.ccm.0000214288.88308.26
116. Stanworth S, Hyde C, Murphy M. Evidence for indications of fresh frozen plasma. Transfusion Clinique et Biologique 2007;14(6):551-556. https://doi.org/10.1016/j.tracli.2008.03.008
117. Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev 2015;29(1): 17-24. https://doi.org/10.1016/j.blre.2014.09.003
118. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010;376(9734):23-32. https://doi.org/10.1016/s0140- 6736(10)60835-5
119. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg 2012;147(2):113-119. https://doi. org/10.1001/archsurg.2011.287
120. Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur HJT. CRASH-3- tranexamic acid for the treatment of significant traumatic brain injury: Study protocol for an international randomised, double-blind, placebo-controlled trial. Trials 2012;13(1):87. https://doi. org/10.1186/1745-6215-13-87
121. Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389(10084):2105- 2116. https://doi.org/10.1016/s0140-6736(17)30638-4
122. Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 2017;376(2):136-148. http://doi.org/10.1056/NEJMoa1606424
123. Bennett C, Klingenberg SL, Langholz E, Gluud LL. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev 2014(11):CD006640.
124. The HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020;395:1927-1935. https://doi.org/10.1016/S0140-6736(20)30848-5
125. Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013;27(4):213-220. https://doi.org/10.1016/j. tmrv.2013.08.004
126. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011(3):CD007871. https://doi.org/10.1002/14651858. cd007871.pub2
127. Wikkelso A, Wetterslev J, Moller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev 2016(8):Cd007871. https://doi.org/10.1002/14651858.cd007871.pub3
128. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007;5(2):289-295. https://doi.org/10.1111/ j.1538-7836.2007.02319.x
129. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011;15(2):R83. https://doi.org/10.1186/cc10078
130. Yin J, Zhao Z, Li Y, et al. Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: A retrospective study. World J Emerg Surg 2014;9:28. https://doi. org/10.1186%2F1749-7922-9-28
131. Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: Developing a thrombelastography(R)-guided transfusion algorithm. Anaesth Intensive Care 2012;40(6):1007-1015. https://doi.org/10.1177/0310057x1204000612
132. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEMguided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015;70(2):166-175. https://doi.org/10.1111/anae.12859
133. Health Professions Council of South Africa. Ethical Guidelines for Good Practice in Healthcare Professions: Booklet 4: Seeking Patient’s Informed Consent: Ethical Considerations. Pretoria: HPCSA; 2016.
134. South Africa. National Health Act, No. 61 of 2003.
135. South Africa. Constitution of the Republic of South Africa, No. 108 of 1996.
136. South Africa. Health Professions Act, No. 56 of 1974.
137. South Africa. Children’s Act, No. 38 of 2005. Sect. 129(2).
138. South Africa. Mental Health Care Act, No. 17 of 2002.
139. McQuoid-Mason D. Parental refusal of blood transfusions for minor children solely on religious grounds - the doctor’s dilemma resolved. S Afr Med J 2008;95(1):29.
140. Ministry of Health (Ontario). Ministry of Health and Long-term Care. Ontario Contingency Plan for the Management of Blood Shortages Version 3. Toronto: Ministry of Health and Long-term Care, 2016.
141. O’Brien KL, Mohammed M, Uhl L. Management of a hospital transfusion service during a nationwide blood product shortage. Arch Pathol Lab Med 2018;142(7):779-781. https://doi. org/10.5858/arpa.2017-0483-le
Critical Care Society of Southern Africa Adult Patient Blood Management Guidelines: 2019 - Round-table meeting, CCSSA Congress, Durban, 2018_SAJCC_July 2020, Vol. 36, No. 1